Loading
NASDAQHealthcareMedical - Healthcare Information Services
Latest quote
$3.48
−$0.05 · -1.42%
GoodRx Holdings, Inc. provides American consumers with essential resources and tools to compare and ultimately lower the cost of their prescription medications. The company operates a digital platform dedicated to price comparison, delivering customized, geographically tailored prescription pricing. It also grants access to special, negotiated rates through unique GoodRx codes, which can be utilized for savings on prescriptions throughout the entire United States. Beyond this core offering, the firm also extends its portfolio to include subscription services, programs designed for pharmaceutical manufacturers, and telehealth capabilities. GoodRx additionally collaborates with pharmacy benefit managers, entities responsible for managing drug formularies and overseeing prescription transactions, including the critical task of setting prices between consumers and pharmacies. The company was founded in 2015 and maintains its principal office in Santa Monica, California.
Latest quote
$3.48
−$0.05 · -1.42%
Regular session · ET · Market data may be delayed.
GoodRx Holdings, Inc. provides American consumers with essential resources and tools to compare and ultimately lower the cost of their prescription medications. The company operates a digital platform dedicated to price comparison, delivering customized, geographically tailored prescription pricing. It also grants access to special, negotiated rates through unique GoodRx codes, which can be utilized for savings on prescriptions throughout the entire United States. Beyond this core offering, the firm also extends its portfolio to include subscription services, programs designed for pharmaceutical manufacturers, and telehealth capabilities. GoodRx additionally collaborates with pharmacy benefit managers, entities responsible for managing drug formularies and overseeing prescription transactions, including the critical task of setting prices between consumers and pharmacies. The company was founded in 2015 and maintains its principal office in Santa Monica, California.
Regular session · ET · Market data may be delayed.
AI-powered factor overview
GoAI Score
Hold
Wait — insufficient conviction to act
Valuation
68
Undervalued
Sentiment
67
Bullish
Risk
71
High Risk
Momentum
46
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
GoodRx Holdings, Inc. provides American consumers with essential resources and tools to compare and ultimately lower the cost of their prescription medications. The company operates a digital platform dedicated to price comparison, delivering customized, geographically tailored prescription pricing. It also grants access to special, negotiated rates through unique GoodRx codes, which can be utilized for savings on prescriptions throughout the entire United States. Beyond this core offering, the firm also extends its portfolio to include subscription services, programs designed for pharmaceutical manufacturers, and telehealth capabilities. GoodRx additionally collaborates with pharmacy benefit managers, entities responsible for managing drug formularies and overseeing prescription transactions, including the critical task of setting prices between consumers and pharmacies. The company was founded in 2015 and maintains its principal office in Santa Monica, California.
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 796.85M USD | 792.32M USD | 750.27M USD | 766.55M USD | 745.42M USD |
| Cost of goods sold | 57.6M USD | 48.22M USD | 66.93M USD | 65.08M USD | 46.72M USD |
| Gross profit | 739.26M USD | 744.11M USD | 683.34M USD | 701.48M USD | 698.71M USD |
| Research and development | 121.03M USD | 123.75M USD | 135.84M USD | 143.14M USD | 125.86M USD |
| Selling, general, and administrative | 445.52M USD | 484.98M USD | 466.84M USD | 502.42M USD | 524.9M USD |
| Operating expenses | 651.76M USD | 678.26M USD | 710.35M USD | 699.74M USD | 685.3M USD |
| Interest income | 10.93M USD | 23.27M USD | 32.17M USD | 9.27M USD | 59K USD |
| Interest expense | 42.61M USD | 52.92M USD | 56.73M USD | 34.24M USD | 23.64M USD |
| Depreciation and amortization | 85.22M USD | 69.54M USD | 107.67M USD | 54.18M USD | 34.54M USD |
| Operating income | 87.49M USD | 65.85M USD | −27.01M USD | 1.74M USD | 13.41M USD |
| Net income | 30.44M USD | 16.39M USD | −8.87M USD | −32.83M USD | −25.25M USD |
Company facts updated Sep 5, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$4.19
20.40% upsideFunds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI8.99M0.00%2.3T USD0.03%$379.73-0.32%
Vanguard Extended Market ETFVXF3.25M0.00%93.7B USD0.05%$242.66+0.14%
Vanguard Morningstar Small-Cap ETFVB3.13M0.00%183.4B USD0.03%$300.01+0.05%
Vanguard Morningstar Small-Cap Value ETFVBR1.99M0.00%68.3B USD0.05%$247.11+0.08%
Dimensional - US Small Cap Value ETFDFSV1.62M0.02%8.42B USD0.30%$40.44+0.50%
Schwab U.S. Small-Cap ETFSCHA1.61M0.01%22.56B USD0.03%$34.55+1.01%
Dimensional - US Targeted Value ETFDFAT1.48M0.01%14.57B USD0.28%$71.82+0.38%
VictoryShares Small Cap Free Cash Flow ETFSFLO982.43K0.11%851.61M USD0.56%$39.93-1.07%Vanguard Morningstar Total Stock Market ETFVTIVanguard Extended Market ETFVXFVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Value ETFVBRDimensional - US Small Cap Value ETFDFSVSchwab U.S. Small-Cap ETFSCHADimensional - US Targeted Value ETFDFATVictoryShares Small Cap Free Cash Flow ETFSFLOAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
